Numab
Investment area
Venture Investments
Region
Europe
Date of investment
April 2021
Numab designs and develops a new class of powerful therapeutics for the treatment of severe diseases. A plug-and-play platform substantially reduces the random nature of the discovery process to predictably yield ready-to-develop multispecific biotherapeutics for chronic inflammation and cancer.